1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
3.1. Market Snapshot
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
5.1. COVID-19 Landscape: Preeclampsia Diagnostics Industry Impact
5.2. COVID 19 - Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
8.1. Preeclampsia Diagnostics Market, by Test Type
8.1.1. Blood Pressure Monitoring
8.1.1.1. Market Revenue and Forecast
8.1.2. Biochemical Marker Assays
8.1.2.1. Market Revenue and Forecast
8.1.3. Urine Protein Tests
8.1.3.1. Market Revenue and Forecast
8.1.4. Imaging-Based Diagnostics (Ultrasound / Doppler)
8.1.4.1. Market Revenue and Forecast
8.1.5. Point-of-Care Testing
8.1.5.1. Market Revenue and Forecast
9.1. Preeclampsia Diagnostics Market, by Technology Type
9.1.1. Immunoassays
9.1.1.1. Market Revenue and Forecast
9.1.2. ELISA / Chemiluminescence-based
9.1.2.1. Market Revenue and Forecast
9.1.3. Molecular / PCR-based Assays
9.1.3.1. Market Revenue and Forecast
9.1.4. Biosensors / Point-of-Care Devices
9.1.4.1. Market Revenue and Forecast
9.1.5. Ultrasound / Imaging-based
9.1.5.1. Market Revenue and Forecast
10.1. Preeclampsia Diagnostics Market, by Test Setting
10.1.1. Laboratory-based Testing
10.1.1.1. Market Revenue and Forecast
10.1.2. Point-of-Care / Bedside Testing
10.1.2.1. Market Revenue and Forecast
10.1.3. Home-based / Remote Monitoring
10.1.3.1. Market Revenue and Forecast
11.1. Preeclampsia Diagnostics Market, by Product & Services
11.1.1. Diagnostic Kits & Reagents
11.1.1.1. Market Revenue and Forecast
11.1.2. Testing Devices & Instruments
11.1.2.1. Market Revenue and Forecast
11.1.3. Laboratory Services
11.1.3.1. Market Revenue and Forecast
11.1.4. Data Analytics & Monitoring Platforms
11.1.4.1. Market Revenue and Forecast
11.1.5. Others
11.1.5.1. Market Revenue and Forecast
12.1. Preeclampsia Diagnostics Market, by End User
12.1.1. Hospitals & Maternity Clinics
12.1.1.1. Market Revenue and Forecast
12.1.2. Diagnostic Laboratories
12.1.2.1. Market Revenue and Forecast
12.1.3. Obstetrics & Gynecology Clinics
12.1.3.1. Market Revenue and Forecast
12.1.4. Research & Academic Institutes
12.1.4.1. Market Revenue and Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by Test Type
13.1.2. Market Revenue and Forecast, by Technology Type
13.1.3. Market Revenue and Forecast, by Test Setting
13.1.4. Market Revenue and Forecast, by Product & Services
13.1.5. Market Revenue and Forecast, by End User
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by Test Type
13.1.6.2. Market Revenue and Forecast, by Technology Type
13.1.6.3. Market Revenue and Forecast, by Test Setting
13.1.6.4. Market Revenue and Forecast, by Product & Services
13.1.6.5. Market Revenue and Forecast, by End User
13.1.7. Rest of North America
13.1.7.1. Market Revenue and Forecast, by Test Type
13.1.7.2. Market Revenue and Forecast, by Technology Type
13.1.7.3. Market Revenue and Forecast, by Test Setting
13.1.7.4. Market Revenue and Forecast, by Product & Services
13.1.7.5. Market Revenue and Forecast, by End User
13.2. Europe
13.2.1. Market Revenue and Forecast, by Test Type
13.2.2. Market Revenue and Forecast, by Technology Type
13.2.3. Market Revenue and Forecast, by Test Setting
13.2.4. Market Revenue and Forecast, by Product & Services
13.2.5. Market Revenue and Forecast, by End User
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by Test Type
13.2.6.2. Market Revenue and Forecast, by Technology Type
13.2.6.3. Market Revenue and Forecast, by Test Setting
13.2.7. Market Revenue and Forecast, by Product & Services
13.2.8. Market Revenue and Forecast, by End User
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by Test Type
13.2.9.2. Market Revenue and Forecast, by Technology Type
13.2.9.3. Market Revenue and Forecast, by Test Setting
13.2.10. Market Revenue and Forecast, by Product & Services
13.2.11. Market Revenue and Forecast, by End User
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by Test Type
13.2.12.2. Market Revenue and Forecast, by Technology Type
13.2.12.3. Market Revenue and Forecast, by Test Setting
13.2.12.4. Market Revenue and Forecast, by Product & Services
13.2.13. Market Revenue and Forecast, by End User
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by Test Type
13.2.14.2. Market Revenue and Forecast, by Technology Type
13.2.14.3. Market Revenue and Forecast, by Test Setting
13.2.14.4. Market Revenue and Forecast, by Product & Services
13.2.15. Market Revenue and Forecast, by End User
13.3. APAC
13.3.1. Market Revenue and Forecast, by Test Type
13.3.2. Market Revenue and Forecast, by Technology Type
13.3.3. Market Revenue and Forecast, by Test Setting
13.3.4. Market Revenue and Forecast, by Product & Services
13.3.5. Market Revenue and Forecast, by End User
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by Test Type
13.3.6.2. Market Revenue and Forecast, by Technology Type
13.3.6.3. Market Revenue and Forecast, by Test Setting
13.3.6.4. Market Revenue and Forecast, by Product & Services
13.3.7. Market Revenue and Forecast, by End User
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by Test Type
13.3.8.2. Market Revenue and Forecast, by Technology Type
13.3.8.3. Market Revenue and Forecast, by Test Setting
13.3.8.4. Market Revenue and Forecast, by Product & Services
13.3.9. Market Revenue and Forecast, by End User
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by Test Type
13.3.10.2. Market Revenue and Forecast, by Technology Type
13.3.10.3. Market Revenue and Forecast, by Test Setting
13.3.10.4. Market Revenue and Forecast, by Product & Services
13.3.10.5. Market Revenue and Forecast, by End User
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by Test Type
13.3.11.2. Market Revenue and Forecast, by Technology Type
13.3.11.3. Market Revenue and Forecast, by Test Setting
13.3.11.4. Market Revenue and Forecast, by Product & Services
13.3.11.5. Market Revenue and Forecast, by End User
13.4. MEA
13.4.1. Market Revenue and Forecast, by Test Type
13.4.2. Market Revenue and Forecast, by Technology Type
13.4.3. Market Revenue and Forecast, by Test Setting
13.4.4. Market Revenue and Forecast, by Product & Services
13.4.5. Market Revenue and Forecast, by End User
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by Test Type
13.4.6.2. Market Revenue and Forecast, by Technology Type
13.4.6.3. Market Revenue and Forecast, by Test Setting
13.4.6.4. Market Revenue and Forecast, by Product & Services
13.4.7. Market Revenue and Forecast, by End User
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by Test Type
13.4.8.2. Market Revenue and Forecast, by Technology Type
13.4.8.3. Market Revenue and Forecast, by Test Setting
13.4.8.4. Market Revenue and Forecast, by Product & Services
13.4.9. Market Revenue and Forecast, by End User
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by Test Type
13.4.10.2. Market Revenue and Forecast, by Technology Type
13.4.10.3. Market Revenue and Forecast, by Test Setting
13.4.10.4. Market Revenue and Forecast, by Product & Services
13.4.10.5. Market Revenue and Forecast, by End User
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by Test Type
13.4.11.2. Market Revenue and Forecast, by Technology Type
13.4.11.3. Market Revenue and Forecast, by Test Setting
13.4.11.4. Market Revenue and Forecast, by Product & Services
13.4.11.5. Market Revenue and Forecast, by End User
13.5. Latin America
13.5.1. Market Revenue and Forecast, by Test Type
13.5.2. Market Revenue and Forecast, by Technology Type
13.5.3. Market Revenue and Forecast, by Test Setting
13.5.4. Market Revenue and Forecast, by Product & Services
13.5.5. Market Revenue and Forecast, by End User
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by Test Type
13.5.6.2. Market Revenue and Forecast, by Technology Type
13.5.6.3. Market Revenue and Forecast, by Test Setting
13.5.6.4. Market Revenue and Forecast, by Product & Services
13.5.7. Market Revenue and Forecast, by End User
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by Test Type
13.5.8.2. Market Revenue and Forecast, by Technology Type
13.5.8.3. Market Revenue and Forecast, by Test Setting
13.5.8.4. Market Revenue and Forecast, by Product & Services
13.5.8.5. Market Revenue and Forecast, by End User
14.1. Thermo Fisher Scientific
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. F. Hoffmann La Roche Ltd
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. PerkinElmer Inc.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. Siemens Healthineers
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Abbott Laboratories
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. Abbott
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Bayer AG
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. QuidelOrtho Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. Diabetomics
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. DRG Instruments GmbH
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
16.1. About Us
16.2. Glossary of Terms
For questions or customization requests, please reach out to us at sales@precedenceresearch.com
No cookie-cutter, only authentic analysis – take the 1st step to become a Precedence Research client
